SSE: 600420
Announcement on Obtaining Drug Registration CertificateThe abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
(600420)"Shanghai Shyndec Pharmaceutical Co., Ltd."Announcement on Obtaining Drug Registration Certificate
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
View original source (Shanghai Stock Exchange)
Earlier from Shanghai Shyndec Pharmaceutical Co., Ltd. Class A
- "Shanghai Shyndec Pharmaceutical Co., Ltd."Announcement on Progress of Provision of Guarantees by a Wholly-owned Subsidiary to Its Subordinate Enterprise
- "Shanghai Shyndec Pharmaceutical Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- "Shanghai Shyndec Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
- "Shanghai Shyndec Pharmaceutical Co., Ltd."Announcement on the Wholly-Owned Subsidiary's Receipt of the Approval Notice for the Marketing Application of a Chemical API